Universal Health Services, Inc. Announces Third Quarter 2018 Earnings Release And Conference Call
KING OF PRUSSIA, Pa., Oct. 15, 2018 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2018 after the market closes on Thursday, October 25, 2018. There will be a conference call for investors and analysts at 9:00 a.m. Eastern Time on Friday, October 26, 2018. The dial-in number is 1-877-648-7971.
A live broadcast of the conference call will be available on the company's website at www.uhsinc.com. Also, a replay of the call will be available following the conclusion of the live call for one full year.
Universal Health Services, Inc. is one of the nation's largest hospital companies operating through its subsidiaries acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, Puerto Rico and the U.S. Virgin Islands.
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...
Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the...
